223 related articles for article (PubMed ID: 12386459)
61. Prolonged transgene expression in cotton rat lung with recombinant adenoviruses defective in E2a.
Engelhardt JF; Litzky L; Wilson JM
Hum Gene Ther; 1994 Oct; 5(10):1217-29. PubMed ID: 7849095
[TBL] [Abstract][Full Text] [Related]
62. Restoration of cyclic adenosine monophosphate-stimulated chloride channel activity in human cystic fibrosis tracheobronchial submucosal gland cells by adenovirus-mediated and cationic lipid-mediated gene transfer.
Jiang C; Finkbeiner WE; Widdicombe JH; Fang SL; Wang KX; Nietupski JB; Hehir KM; Cheng SH
Am J Respir Cell Mol Biol; 1999 Jun; 20(6):1107-15. PubMed ID: 10340929
[TBL] [Abstract][Full Text] [Related]
63. Non-viral gene transfer therapy for cystic fibrosis.
Ziady AG; Davis PB; Konstan MW
Expert Opin Biol Ther; 2003 Jun; 3(3):449-58. PubMed ID: 12783613
[TBL] [Abstract][Full Text] [Related]
64. Suitability of oligonucleotide-mediated cystic fibrosis gene repair in airway epithelial cells.
de Semir D; Nadal M; González JR; Larriba S; Avinyó A; Nunes V; Casals T; Estivill X; Aran JM
J Gene Med; 2003 Jul; 5(7):625-39. PubMed ID: 12825202
[TBL] [Abstract][Full Text] [Related]
65. Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans.
Grubb BR; Pickles RJ; Ye H; Yankaskas JR; Vick RN; Engelhardt JF; Wilson JM; Johnson LG; Boucher RC
Nature; 1994 Oct; 371(6500):802-6. PubMed ID: 7523956
[TBL] [Abstract][Full Text] [Related]
66. Progress in gene and cell therapy for cystic fibrosis lung disease.
Griesenbach U; Alton EW
Curr Pharm Des; 2012; 18(5):642-62. PubMed ID: 22229571
[TBL] [Abstract][Full Text] [Related]
67. A low rate of cell proliferation and reduced DNA uptake limit cationic lipid-mediated gene transfer to primary cultures of ciliated human airway epithelia.
Fasbender A; Zabner J; Zeiher BG; Welsh MJ
Gene Ther; 1997 Nov; 4(11):1173-80. PubMed ID: 9425440
[TBL] [Abstract][Full Text] [Related]
68. Gene therapy for cystic fibrosis using E1-deleted adenovirus: a phase I trial in the nasal cavity. The University of North Carolina at Chapel Hill.
Boucher RC; Knowles MR; Johnson LG; Olsen JC; Pickles R; Wilson JM; Engelhardt J; Yang Y; Grossman M
Hum Gene Ther; 1994 May; 5(5):615-39. PubMed ID: 7519885
[TBL] [Abstract][Full Text] [Related]
69. Novel therapies for the treatment of cystic fibrosis: new developments in gene and stem cell therapy.
Sueblinvong V; Suratt BT; Weiss DJ
Clin Chest Med; 2007 Jun; 28(2):361-79. PubMed ID: 17467554
[TBL] [Abstract][Full Text] [Related]
70. Terminal glycosylation in cystic fibrosis.
Scanlin TF; Glick MC
Biochim Biophys Acta; 1999 Oct; 1455(2-3):241-53. PubMed ID: 10571016
[TBL] [Abstract][Full Text] [Related]
71. Antibacterial effect and DNA delivery using a combination of an arsonium-containing lipophosphoramide with an N-heterocyclic carbene-silver complex - Potential benefits for cystic fibrosis lung gene therapy.
Mottais A; Berchel M; Sibiril Y; Laurent V; Gill D; Hyde S; Jaffrès PA; Montier T; Le Gall T
Int J Pharm; 2018 Jan; 536(1):29-41. PubMed ID: 29138047
[TBL] [Abstract][Full Text] [Related]
72. Gene therapy for cystic fibrosis.
Johnson LG
Chest; 1995 Feb; 107(2 Suppl):77S-83S. PubMed ID: 7842818
[TBL] [Abstract][Full Text] [Related]
73. In vivo evaluation of the safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lung.
Yei S; Mittereder N; Wert S; Whitsett JA; Wilmott RW; Trapnell BC
Hum Gene Ther; 1994 Jun; 5(6):731-44. PubMed ID: 7948135
[TBL] [Abstract][Full Text] [Related]
74. Long-term therapeutic and reporter gene expression in lentiviral vector treated cystic fibrosis mice.
Cmielewski P; Donnelley M; Parsons DW
J Gene Med; 2014; 16(9-10):291-9. PubMed ID: 25130650
[TBL] [Abstract][Full Text] [Related]
75. Liposomes and viruses for gene therapy of cystic fibrosis.
Coutelle C; Williamson R
J Aerosol Med; 1996; 9(1):79-88. PubMed ID: 10160212
[TBL] [Abstract][Full Text] [Related]
76. Inhibition by TNF-alpha and IL-4 of cationic lipid mediated gene transfer in cystic fibrosis tracheal gland cells.
Bastonero S; Gargouri M; Ortiou S; Guéant JL; Merten MD
J Gene Med; 2005 Nov; 7(11):1439-49. PubMed ID: 16001392
[TBL] [Abstract][Full Text] [Related]
77. Barriers to and new approaches for gene therapy and gene delivery in cystic fibrosis.
Ferrari S; Geddes DM; Alton EW
Adv Drug Deliv Rev; 2002 Dec; 54(11):1373-93. PubMed ID: 12458150
[TBL] [Abstract][Full Text] [Related]
78. A receptor-targeted nanocomplex vector system optimized for respiratory gene transfer.
Tagalakis AD; McAnulty RJ; Devaney J; Bottoms SE; Wong JB; Elbs M; Writer MJ; Hailes HC; Tabor AB; O'Callaghan C; Jaffe A; Hart SL
Mol Ther; 2008 May; 16(5):907-15. PubMed ID: 18388925
[TBL] [Abstract][Full Text] [Related]
79. Cystic fibrosis gene therapy: a mutation-independent treatment.
Griesenbach U; Davies JC; Alton E
Curr Opin Pulm Med; 2016 Nov; 22(6):602-9. PubMed ID: 27583674
[TBL] [Abstract][Full Text] [Related]
80. Non-viral and hybrid vectors in human gene therapy: an update.
Schmidt-Wolf GD; Schmidt-Wolf IG
Trends Mol Med; 2003 Feb; 9(2):67-72. PubMed ID: 12615040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
